Regulatory & Recall Risk DermaRite has faced multiple voluntary recalls for microbial contamination with Burkholderia cepacia complex, including sepsis concerns and infection risks across creams, soaps, and sanitizers. This presents an opportunity to position high-quality, thoroughly tested wound care and skin care products with proven safety profiles and robust QA documentation to healthcare facilities seeking to minimize recall exposure.

Clinical Support Value The company offers access to clinical and educational tools alongside product lines. This can be leveraged to upsell bundled solutions that include training resources, wound care protocols, and patient care guidelines, strengthening partnerships with hospitals, nursing homes, and home care providers.

National Distribution Reach With a nationwide distribution and sales network and a manufacturing facility in New Jersey, DermaRite can support rapid replenishment and consistent product availability for hospitals and long-term care facilities across regions, addressing supply reliability concerns common in facility procurement.

Cost-Effective Solutions Position DermaRite as a value-oriented supplier of skin care, wound care, and nutritional products suitable for cost-conscious facilities. Emphasize total cost of ownership, bulk purchasing options, and longer-term contracts to secure stable revenue streams.

Growth Opportunities in Wound Care Given the focus on wound care products and the growth in post-acute and home-based care, target expansion into bundled wound management programs, complementary nutrition support, and antiseptic products that align with infection-prevention initiatives while addressing the recall history with enhanced safety assurances.